Genetic and epigenetic analyses of MBD3 in colon and lung cancer

Y Zhu; D J Harrison; S A Bader

doi:10.1038/sj.bjc.6601776

Genetic and epigenetic analyses of MBD3 in colon and lung cancer

Y Zhu, D J Harrison, S A Bader

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

MBD3: is a member of the methyl-CpG-binding domain family and is located on chromosome 19p13.3, a region of loss of heterozygosity in colon and lung cancers. We therefore screened samples for abnormalities in MBD3. Our results indicate that MBD3 is not a major target of genetic and epigenetic alteration in these cancers.

Original language	English
Pages (from-to)	1972-1975
Number of pages	4
Journal	British Journal of Cancer
Volume	90
Issue number	10
Early online date	13 Apr 2004
DOIs	https://doi.org/10.1038/sj.bjc.6601776
Publication status	Published - 17 May 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

MBD3
Colon cancer
Lung cancer
Mutation
Methylation

Access to Document

10.1038/sj.bjc.6601776

zhu2004bjc1972
Copyright 2004 Cancer Research UK. From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Final published version, 101 KB

Handle.net

Persistent link

Cite this

@article{1fbaf97c061b4b89844ebfa58ff94637,

title = "Genetic and epigenetic analyses of MBD3 in colon and lung cancer",

abstract = "MBD3: is a member of the methyl-CpG-binding domain family and is located on chromosome 19p13.3, a region of loss of heterozygosity in colon and lung cancers. We therefore screened samples for abnormalities in MBD3. Our results indicate that MBD3 is not a major target of genetic and epigenetic alteration in these cancers.",

keywords = "MBD3, Colon cancer, Lung cancer, Mutation, Methylation",

author = "Y Zhu and Harrison, \{D J\} and Bader, \{S A\}",

year = "2004",

month = may,

day = "17",

doi = "10.1038/sj.bjc.6601776",

language = "English",

volume = "90",

pages = "1972--1975",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

number = "10",

}

TY - JOUR

T1 - Genetic and epigenetic analyses of MBD3 in colon and lung cancer

AU - Zhu, Y

AU - Harrison, D J

AU - Bader, S A

PY - 2004/5/17

Y1 - 2004/5/17

N2 - MBD3: is a member of the methyl-CpG-binding domain family and is located on chromosome 19p13.3, a region of loss of heterozygosity in colon and lung cancers. We therefore screened samples for abnormalities in MBD3. Our results indicate that MBD3 is not a major target of genetic and epigenetic alteration in these cancers.

AB - MBD3: is a member of the methyl-CpG-binding domain family and is located on chromosome 19p13.3, a region of loss of heterozygosity in colon and lung cancers. We therefore screened samples for abnormalities in MBD3. Our results indicate that MBD3 is not a major target of genetic and epigenetic alteration in these cancers.

KW - MBD3

KW - Colon cancer

KW - Lung cancer

KW - Mutation

KW - Methylation

UR - http://www.nature.com/bjc/journal/v90/n10/full/6601776a.html

UR - https://www.scopus.com/pages/publications/2942622687

U2 - 10.1038/sj.bjc.6601776

DO - 10.1038/sj.bjc.6601776

M3 - Article

SN - 0007-0920

VL - 90

SP - 1972

EP - 1975

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 10

ER -

Genetic and epigenetic analyses of MBD3 in colon and lung cancer

Abstract

UN SDGs

Keywords

Access to Document

Handle.net

Other files and links

Fingerprint

Cite this